Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Proteinuria Reduction
.
Show all posts
Showing posts with label
Proteinuria Reduction
.
Show all posts
Monday, June 16, 2025
FDA Grants Accelerated Approval for Vanrafia (atrasentan) for Proteinuria Reduction in Primary IgA Nephropathy
›
Novartis announced the US Food and Drug Administration (FDA) accelerated approval for Vanrafia ® (atrasentan), a potent and selective end...
›
Home
View web version
